Received May 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Slight diabetes; This spontaneous case was reported by a consumer and describes the occurrence of DIABETES MELLITUS (Slight diabetes) in a 78-year-old male patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Concurrent medical conditions included Blood pressure high. In 2024, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. On an unknown date, received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIABETES MELLITUS (Slight diabetes) (seriousness criterion medically significant). At the time of the report, DIABETES MELLITUS (Slight diabetes) had not resolved. Concomitant medication use information was not provided by reporter. It was reported that the patient had three COVID-19 shots in the past year and a half. When asked if the patient received the Moderna COVID vaccines, it was reported that the patient had both, in different times and different places. It was reported that the patient believed that the diabetes started around the same time as the vaccines. It was unknown if the patient experienced any additional symptoms/events. Treatment medication use information was not provided by reporter. Reporter did not allow further contact; Reporter's Comments: The benefit-risk relationship of product is not affected by this report.
Blood pressure high